Shannon Grabosch

425 total citations
15 papers, 326 citations indexed

About

Shannon Grabosch is a scholar working on Oncology, Immunology and Pharmacology. According to data from OpenAlex, Shannon Grabosch has authored 15 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Shannon Grabosch's work include Endometrial and Cervical Cancer Treatments (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shannon Grabosch is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shannon Grabosch collaborates with scholars based in United States, United Kingdom and China. Shannon Grabosch's co-authors include Robert P. Edwards, Anda Vlad, Lixin Zhang, Esther Elishaev, Tianzhou Ma, George C. Tseng, Andrea Gambotto, Yusi Fang, Mirna Bulatović and Malcolm S. Ross and has published in prestigious journals such as Oncogene, Cochrane Database of Systematic Reviews and American Journal of Obstetrics and Gynecology.

In The Last Decade

Shannon Grabosch

13 papers receiving 323 citations

Peers

Shannon Grabosch
Teresa Smit South Africa
Vadim Kurbatov United States
Imène Hamaidi United States
U. Dafni Switzerland
Shannon Grabosch
Citations per year, relative to Shannon Grabosch Shannon Grabosch (= 1×) peers Rourou Xiao

Countries citing papers authored by Shannon Grabosch

Since Specialization
Citations

This map shows the geographic impact of Shannon Grabosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Grabosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Grabosch more than expected).

Fields of papers citing papers by Shannon Grabosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Grabosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Grabosch. The network helps show where Shannon Grabosch may publish in the future.

Co-authorship network of co-authors of Shannon Grabosch

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Grabosch. A scholar is included among the top collaborators of Shannon Grabosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Grabosch. Shannon Grabosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gavard, Jeffrey A., et al.. (2022). Optimizing prehabilitation in gynecologic oncology (476). Gynecologic Oncology. 166. S236–S236.
2.
Gavard, Jeffrey A., et al.. (2022). P16 Optimizing prehabilitation in gynecologic oncology. Gynecologic Oncology. 165. S14–S14.
3.
Grabosch, Shannon, et al.. (2020). Granulosa cell tumor resection with subsequent onset of rheumatoid arthritis. Gynecologic Oncology Reports. 34. 100678–100678. 1 indexed citations
4.
Boakye, Eric Adjei, et al.. (2020). Risk of second primary cancers among survivors of gynecological cancers. Gynecologic Oncology. 158(3). 719–726. 16 indexed citations
5.
Grabosch, Shannon, Mirna Bulatović, Tianzhou Ma, et al.. (2018). Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles. Oncogene. 38(13). 2380–2393. 214 indexed citations
6.
Grabosch, Shannon, et al.. (2018). Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews. 2019(4). 12 indexed citations
7.
Grabosch, Shannon, George C. Tseng, Robert P. Edwards, et al.. (2017). Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. 146(1). 137–145. 4 indexed citations
8.
Grabosch, Shannon, Furong Zeng, Tonghui Ma, et al.. (2016). Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer. Gynecologic Oncology. 141. 86–86. 1 indexed citations
9.
Zhang, Lixin, Tianzhou Ma, Shannon Grabosch, et al.. (2015). Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model. Cancer Immunology Immunotherapy. 64(9). 1095–1108. 19 indexed citations
10.
Grabosch, Shannon, et al.. (2015). PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer. Journal for ImmunoTherapy of Cancer. 3(S2). 17 indexed citations
11.
Grabosch, Shannon, et al.. (2014). Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews. 2(4). CD004121–CD004121. 22 indexed citations
12.
Grabosch, Shannon, et al.. (2013). Short Bowel Syndrome Causing Bleeding Diathesis and Profound Vitamin Deficiency in Pregnancy. Obstetrics and Gynecology. 121(Part 2). 434–436. 3 indexed citations
13.
Grabosch, Shannon, et al.. (2013). Isolated Port-Site Metastasis After Robotic Hysterectomy for Stage IA Endometrial Adenocarcinoma. Obstetrics and Gynecology. 122(2). 437–439. 9 indexed citations
14.
Grabosch, Shannon, Jeffrey A. Gavard, & Dorothea Mostello. (2013). 151: Text4baby improves glycemic control in pregnant women with diabetes. American Journal of Obstetrics and Gynecology. 210(1). S88–S88. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026